首页> Bone marrow transplantation> Use of rituximab and irradiated donor-derived lymphocytes to control Epstein-Barr virus-associated lymphoproliferation in patients undergoing related haplo-identical stem cell transplantation.

Use of rituximab and irradiated donor-derived lymphocytes to control Epstein-Barr virus-associated lymphoproliferation in patients undergoing related haplo-identical stem cell transplantation.

导出原文传递

翻译打印收藏纠错

作者： McGuirk JP ^[1] ; Seropian S ; Howe G ; Smith B ; Stoddart L ; Cooper DL

作者单位： Blood and Marrow Transplant Program, Yale University School of Medicine, New Haven, Connecticut 06520-8032, USA. ^[1]

关键词 Antibodies Monoclonal Hematopoietic Stem Cell Transplantation Herpesvirus 4 Human 抗体单克隆造血干细胞移植疱疹病毒4型人淋巴细胞淋巴组织增殖性疾病

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Bone marrow transplantation

1999年24卷11期

1253-1258页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Bone marrow transplantation

1999年24卷11期

1253-1258页

检索历史清除

Use of rituximab and irradiated donor-derived lymphocytes to control Epstein-Barr virus-associated lymphoproliferation in patients undergoing related haplo-identical stem cell transplantation.

Bone marrow transplantation

相似文献

Bone marrow transplantation

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Use of rituximab and irradiated donor-derived lymphocytes to control Epstein-Barr virus-associated lymphoproliferation in patients undergoing related haplo-identical stem cell transplantation.

Bone marrow transplantation

相似文献

Bone marrow transplantation

相关期刊

检索历史清除